Ketogenic diets as an adjuvant therapy in glioblastoma (the KEATING trial): study protocol for a randomised pilot study

BACKGROUND: Glioblastoma is the commonest form of malignant brain tumour in adults, affecting 2–3 people per 100,000 per year. Despite current treatment options including surgical resection, radiotherapy and temozolomide chemotherapy, overall survival at 2 years is approximately 27%, with a median s...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-McGill, Kirsty J., Marson, Anthony G., Tudur Smith, Catrin, Jenkinson, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704454/
https://www.ncbi.nlm.nih.gov/pubmed/29209515
http://dx.doi.org/10.1186/s40814-017-0209-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704454/
https://www.ncbi.nlm.nih.gov/pubmed/29209515
http://dx.doi.org/10.1186/s40814-017-0209-9

Ejemplares similares